We look at the long-term situation regarding tick-borne encephalitis in Europe, and an editorial highlights a number of challenges and remaining questions related to this disease.
Eurosurveillance, Volume 13, Issue 17, 24 April 2008
Table of Contents
What is now known as tick-borne encephalitis (TBE) was first recognised as a distinct disease entity in 1931 in Europe by H. Schneider and described as 'meningitis serosa epidemica' of unknown etiology. A disease with similar clinical symptoms was reported in the Far East in 1934 and briefly thereafter - in 1937 - the etiologic agent was isolated in Russia and its transmission by ticks could also be demonstrated.
Between 20 January and 10 April 2008, six probable Crimean-Congo-haemorrhagic fever (CCHF) cases were reported in the municipality of Gotse Delchev, in Blagoevgrad district.
Haemorrhagic fever with renal syndrome (HFRS) is an acute zoonotic viral disease, caused by hantaviruses. Hantaviruses infect rodents worldwide. They are transmitted to humans by aerosol from rodent excreta. Several hantaviruses are known to infect humans with varying severity.
Campylobacteriosis is the most common reported bacterial gastrointestinal disease in Sweden. Food-borne outbreaks of campylobacteriosis in Sweden are rather rare except for, usually rather small, family outbreaks. Water-borne outbreaks of campylobacteriosis, however, have affected several thousand persons in the past.
Surveillance and outbreak reports
The European Network for Diagnostics of “Imported” Viral Diseases (ENIVD) is finalising a project to improve the diagnostic and monitoring of encephalitis viruses in Europe. Part of this study was to analyse the present surveillance situation for tick-borne encephalitis (TBE), which is the most important flavivirus infection of the central nervous system in the European Union (EU) and Russia.
For the last three years, Austria has been considered a low-moderate incidence country (< 1/100,000/year) for measles - the last significant outbreak of the disease occurred in 2003, involving 64 cases.
As of this week, Eurosurveillance has a new website. The radical change in the lay-out of the journal follows the merging of the two previous electronic editions in January 2008.
Eurosurveillance Edition: 24 April 2008
The opinions expressed by authors contributing to Eurosurveillance
do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance
site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence
. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Eurosurveillance [ISSN] - ©2007-2016. All rights reserved